Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.26824 | 10 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.2654 | 11 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.2583 | 10 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.18927 | 9 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.24439 | 12 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.30117 | 10 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.25957 | 10 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.2714 | 12 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.24782 | 11 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.25796 | 11 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.25332 | 11 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.23746 | 11 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.26149 | 11 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.26186 | 11 |